Pneumoconiosis

Pneumoconiosis refers to a group of lung diseases arising from inhalation of mineral dust, usually in the context of certain occupations ^[1]. The condition is characterized pathologically by chronic pulmonary inflammation and progressive pulmonary fibrosis ^[1]. The source material frames pneumoconiosis as an occupational health concept and places it within ICD-10 codes J60-J64 ^[1].

The main described pathological process is chronic pulmonary inflammation with progressive pulmonary fibrosis ^[1]. In advanced disease, this progression can lead to death from respiratory and/or heart failure ^[1]. For silica-related pneumoconiosis, the source notes that silicosis is potentially fatal and may be progressive or even fatal despite prevention efforts ^[2]. The provided sources do not supply a fuller symptom inventory, staging scheme, or timing of progression.

The available literature describes pneumoconiosis as widespread globally and a serious public-health threat ^[1]. Occupational exposure burden is noted to be substantial, with millions of workers exposed to substances that can cause occupational interstitial lung diseases, particularly in developing countries ^[3]. For silicosis specifically, the sources state that it was historically associated with miners but has re-emerged in multiple settings worldwide, including sandblasting denim jeans and manufacturing artificial stone benchtops ^[2]. The burden may be underestimated because of under-recognition and under-reporting ^[3].

Pneumoconiosis is not described as being transmitted person-to-person; rather, it results from inhalation of mineral dust, usually through occupational exposure ^[1]. In the silica-related source, the implicated exposure is respirable crystalline silica ^[2]. The evidence provided does not specify persistence in the environment or other non-occupational exposure pathways.

The source material indicates that affected populations are typically workers exposed to mineral dust in certain occupations ^[1]. Historically, miners are highlighted as a major risk group for silicosis, and contemporary risk has also been described in workers involved in sandblasting denim jeans and manufacturing artificial stone benchtops ^[2]. More broadly, workers exposed to substances that cause occupational interstitial lung disease are at risk, particularly in developing countries ^[3].

Prevention in the provided sources centers on occupational exposure control and safeguard procedures ^[1]. Improper occupational protection is identified as a major contributor to high incidence and mortality, and silicosis is explicitly described as completely preventable ^[1][2]. The occupational ILD review emphasizes removal from workplace exposure as a key intervention and highlights the importance of surveillance and prevention to reduce disease burden ^[3].

In surveillance terms, pneumoconiosis should be interpreted as an occupationally linked chronic lung disease whose burden may be underestimated because of under-recognition and under-reporting ^[3]. The sources emphasize the need for a careful occupational history and a high level of suspicion, since occupational and non-occupational interstitial lung diseases may be clinically, functionally, and radiologically indistinguishable ^[3]. Monitoring should therefore pay attention to workplace exposure patterns and emerging contemporary risk settings, not only traditional mining exposures ^[2][3].

1. 1 Qi XM et al. Pneumoconiosis: current status and future prospects. Chin Med J (Engl). 2021 Apr 13. PMID: 33879753. doi: 10.1097/CM9.0000000000001461. PubMed: https://pubmed.ncbi.nlm.nih.gov/33879753/
2. 2 Hoy RF et al. Silica-related diseases in the modern world. Allergy. 2020 Nov. PMID: 31989662. doi: 10.1111/all.14202. PubMed: https://pubmed.ncbi.nlm.nih.gov/31989662/
3. 3 Spagnolo P et al. Occupational interstitial lung diseases. J Intern Med. 2023 Dec. PMID: 37535448. doi: 10.1111/joim.13707. PubMed: https://pubmed.ncbi.nlm.nih.gov/37535448/
4. 4 Pneumoconiosis. Occupational Medicine. 1954. doi: 10.1093/occmed/4.1.33. DOI: https://doi.org/10.1093/occmed/4.1.33
5. 5 The Prevention of Pneumoconiosis (Pneumoconiosis). Sangyo Igaku. 1960. doi: 10.1539/joh1959.2.4_287. DOI: https://doi.org/10.1539/joh1959.2.4_287
6. 6 Pneumoconiosis. Medicine. 2008. doi: 10.1016/j.mpmed.2008.02.002. DOI: https://doi.org/10.1016/j.mpmed.2008.02.002

ICD-10

J60-J64

ICD-11

Total cases

5K

Peak month

2008-10

Coverage

1 reporting countries · 2007-02-01 → 2024-12-01